GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » BRAIN Biotech AG (CHIX:BNNd) » Definitions » EV-to-Revenue

BRAIN Biotech AG (CHIX:BNND) EV-to-Revenue : 0.90 (As of Jun. 23, 2024)


View and export this data going back to 2018. Start your Free Trial

What is BRAIN Biotech AG EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, BRAIN Biotech AG's enterprise value is €49.85 Mil. BRAIN Biotech AG's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €55.37 Mil. Therefore, BRAIN Biotech AG's EV-to-Revenue for today is 0.90.

The historical rank and industry rank for BRAIN Biotech AG's EV-to-Revenue or its related term are showing as below:

CHIX:BNNd' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.98   Med: 4.86   Max: 20.84
Current: 0.89

During the past 9 years, the highest EV-to-Revenue of BRAIN Biotech AG was 20.84. The lowest was 0.98. And the median was 4.86.

CHIX:BNNd's EV-to-Revenue is ranked better than
69.69% of 1534 companies
in the Chemicals industry
Industry Median: 1.545 vs CHIX:BNNd: 0.89

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-23), BRAIN Biotech AG's stock price is €5.86. BRAIN Biotech AG's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €2.54. Therefore, BRAIN Biotech AG's PS Ratio for today is 2.31.


BRAIN Biotech AG EV-to-Revenue Historical Data

The historical data trend for BRAIN Biotech AG's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BRAIN Biotech AG EV-to-Revenue Chart

BRAIN Biotech AG Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 5.34 3.33 5.20 2.07 1.68

BRAIN Biotech AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.16 1.68 1.68 1.47 1.27

Competitive Comparison of BRAIN Biotech AG's EV-to-Revenue

For the Specialty Chemicals subindustry, BRAIN Biotech AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BRAIN Biotech AG's EV-to-Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, BRAIN Biotech AG's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where BRAIN Biotech AG's EV-to-Revenue falls into.



BRAIN Biotech AG EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BRAIN Biotech AG's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=49.854/55.368
=0.90

BRAIN Biotech AG's current Enterprise Value is €49.85 Mil.
BRAIN Biotech AG's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €55.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BRAIN Biotech AG  (CHIX:BNNd) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BRAIN Biotech AG's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=5.86/2.535
=2.31

BRAIN Biotech AG's share price for today is €5.86.
BRAIN Biotech AG's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.54.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BRAIN Biotech AG EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of BRAIN Biotech AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BRAIN Biotech AG (CHIX:BNND) Business Description

Traded in Other Exchanges
Address
Darmstadter Strasse 34-36, Zwingenberg, BW, DEU, 64673
BRAIN Biotech AG is a technology company in the field of industrial biotechnology. It serves the chemical and consumer goods industries. The company develops novel biological ingredients such as enzymes, biocatalysts, and bioactive natural compounds. The company's segments include, BioProducts, BioScience and BioIncubator. Majority of the revenue is generated from its BioProducts segment which comprises of the product business with enzymes and other proteins for specific segments of the food industry. Geographically, the company generates majority of the revenue from United States of America and also has presence in other markets such as, Germany, France, United Kingdom and Netherlands.

BRAIN Biotech AG (CHIX:BNND) Headlines

No Headlines